semaglutide cardiovascular outcomes 2025 news risk reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial semaglutide cardiovascular outcomes news 2025

US$ 24.87

★★★★★ 5.0 (18 reviews)

US$ 24.31

★★★★★ 5.0 (13 reviews)

US$ 23.23

★★★★★ 5.0 (27 reviews)

US$ 26.86

★★★★★ 5.0 (25 reviews)

US$ 28.32

★★★★★ 4.8 (28 reviews)

US$ 29.65

★★★★★ 5.0 (10 reviews)

US$ 22.62

★★★★★ 4.7 (26 reviews)

US$ 21.83

★★★★★ 4.4 (29 reviews)

US$ 23.05

★★★★★ 4.0 (26 reviews)

US$ 22.27

★★★★★ 4.2 (28 reviews)

US$ 20.94

★★★★★ 4.9 (25 reviews)

US$ 29.12

★★★★★ 4.9 (20 reviews)

US$ 26.99

★★★★★ 4.2 (16 reviews)

US$ 26.20

★★★★★ 5.0 (9 reviews)

US$ 29.07

★★★★★ 4.6 (14 reviews)

US$ 20.95

★★★★★ 4.0 (20 reviews)

US$ 22.83

★★★★★ 4.1 (20 reviews)

US$ 27.01

★★★★★ 4.3 (20 reviews)

US$ 26.81

★★★★★ 4.7 (15 reviews)

US$ 26.67

★★★★★ 4.5 (10 reviews)